Literature DB >> 9371546

Alpha2-adrenoceptor regulation of adenylyl cyclase in CHO cells: dependence on receptor density, receptor subtype and current activity of adenylyl cyclase.

K Pohjanoksa1, C C Jansson, K Luomala, A Marjamäki, J M Savola, M Scheinin.   

Abstract

Chinese hamster ovary (CHO) cells stably transfected to express different densities of the human alpha2A-, alpha2B- and alpha2C-adrenoceptor subtypes, were used to characterize the regulation of adenylyl cyclase activity by alpha2-adrenoceptor agonists. In isolated cell membranes, activation of alpha2A- and alpha2C-adrenoceptors did not affect basal enzyme activity, but activation of alpha2B-adrenoceptors stimulated adenylyl cyclase activity. The extent of stimulation was dependent on the receptor density and was insensitive to pertussis toxin treatment. In the presence of 10 microM forskolin all three receptor subtypes mediated inhibition of adenylyl cyclase activity in a pertussis toxin-sensitive manner. In experiments performed with intact cells the same pattern could be seen: the basal production of cAMP was not affected when alpha2C-adrenoceptors were activated, but activated alpha2B-adrenoceptors mediated stimulation of cAMP production. In the presence of forskolin, both receptor subtypes mediated inhibition of cAMP production. Our results suggest that alpha2B-adrenoceptors are coupled to both Gi and Gs proteins. The signal transduction pathway to which the receptor is coupled is not dependent on receptor density, but its effect on adenylyl cyclase regulation is dependent on the current activity of adenylyl cyclase. The results also suggest that the alpha2A- and alpha2C-subtypes are preferentially coupled to Gi and transduce only inhibition of adenylyl cyclase activity in transfected CHO cells. At low densities of alpha2C-adrenoceptors, clonidine was a partial agonist, but in clones expressing high levels of alpha2C-adrenoceptors, clonidine acted as a full agonist by inhibiting cAMP accumulation with the same efficacy as (-)-noradrenaline. This demonstrates that receptor reserve can mask partial agonist activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371546     DOI: 10.1016/s0014-2999(97)01154-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  17 in total

1.  Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302.

Authors:  J Sallinen; I Höglund; M Engström; J Lehtimäki; R Virtanen; J Sirviö; S Wurster; J-M Savola; A Haapalinna
Journal:  Br J Pharmacol       Date:  2007-01-15       Impact factor: 8.739

2.  Pharmacological profile of intrathecal fadolmidine, a alpha2-adrenoceptor agonist, in rodent models.

Authors:  Tiina Leino; Timo Viitamaa; Antti Haapalinna; Jyrki Lehtimäki; Raimo Virtanen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-10-14       Impact factor: 3.000

3.  Conserved structural, pharmacological and functional properties among the three human and five zebrafish alpha 2-adrenoceptors.

Authors:  Jori O Ruuskanen; Jonne Laurila; Henri Xhaard; Ville-Veikko Rantanen; Karoliina Vuoriluoto; Siegfried Wurster; Anne Marjamäki; Minna Vainio; Mark S Johnson; Mika Scheinin
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

4.  Involvement of the first transmembrane segment of human α(2) -adrenoceptors in the subtype-selective binding of chlorpromazine, spiperone and spiroxatrine.

Authors:  J M M Laurila; G Wissel; H Xhaard; J O Ruuskanen; M S Johnson; M Scheinin
Journal:  Br J Pharmacol       Date:  2011-11       Impact factor: 8.739

5.  A comparison of agonist-specific coupling of cloned human alpha(2)-adrenoceptor subtypes.

Authors:  J E Rudling; J Richardson; P D Evans
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

6.  Voltage regulates adrenergic receptor function.

Authors:  Andreas Rinne; Alexandra Birk; Moritz Bünemann
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

7.  Agonist trafficking of G(i/o)-mediated alpha(2A)-adrenoceptor responses in HEL 92.1.7 cells.

Authors:  J P Kukkonen; C C Jansson; K E Akerman
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

8.  Molecular mechanisms of ligand-receptor interactions in transmembrane domain V of the alpha2A-adrenoceptor.

Authors:  Juha M Peltonen; Tommi Nyrönen; Siegfried Wurster; Marjo Pihlavisto; Anna-Marja Hoffrén; Anne Marjamäki; Henri Xhaard; Liisa Kanerva; Juha-Matti Savola; Mark S Johnson; Mika Scheinin
Journal:  Br J Pharmacol       Date:  2003-08-18       Impact factor: 8.739

9.  α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands.

Authors:  Marta Sánchez-Soto; Verònica Casadó-Anguera; Hideaki Yano; Brian Joseph Bender; Ning-Sheng Cai; Estefanía Moreno; Enric I Canela; Antoni Cortés; Jens Meiler; Vicent Casadó; Sergi Ferré
Journal:  Mol Neurobiol       Date:  2018-03-18       Impact factor: 5.590

10.  Involvement of signaling pathways in bovine sperm motility, and effect of ergot alkaloids.

Authors:  Hehai Wang; Michael L Looper; Zelpha B Johnson; Rick W Rorie; Charles F Rosenkrans
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-05-19       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.